19-28z CAR T cells: Phase II halted

Juno said FDA halted the open-label, U.S. Phase II ROCKET trial evaluating IV JCAR015 following 2 patient deaths from cerebral edema. Juno said a third ROCKET

Read the full 264 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE